Acute Lymphoblastic Leukemia

Amgen tops Street 4Q forecasts

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

Jan 27, 2015
popularity 2 comments 0

Findings on insomnia in children and cancer

College of Nursing colleagues Ellyn Matthews, PhD, RN, AOCNS, CBSM, Madalynn Neu, PhD, RN, and Paul Cook, PhD, have published research findings on sleep among children with acute lymphoblastic leukemia (ALL) and their mothers.

Dec 17, 2014
popularity 0 comments 0

Blincyto approved for rare leukemia

(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.

Dec 03, 2014
popularity 0 comments 0

Immune therapy induces remission for many with ALL

(HealthDay)—An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options, according to research published ...

Oct 16, 2014
popularity 0 comments 0

Latest Spotlight News

Making waves with groundbreaking brain research

New research by Jason Gallivan and Randy Flanagan suggests that when deciding which of several possible actions to perform, the human brain plans multiple actions simultaneously prior to selecting one of ...

Walking in nature found to reduce rumination

(Medical Xpress)—A team of researchers working at Stanford University has found that people walking in a "natural" environment tend to engage in less rumination. In their paper published in Proceedings of ...

Can autism be measured in a sniff?

Imagine the way you might smell a rose. You'd take a nice big sniff to breathe in the sweet but subtle floral scent. Upon walking into a public restroom, you'd likely do just the opposite—abruptly limiting ...